IL11 and prostate carcinoma: Through direct selection of peptide libraries in patients [1], [37], [38], we isolated a ligand peptide mimicking IL-11 from the prostate vasculature [1] and proposed the IL-11Rα as a target during the progression of prostate cancer [2].